Back to Markets
SPARS Pharmaceuticals Inc

ARS Pharmaceuticals Inc

SPRYNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$9.07

-0.330000 (-3.51%)

As of 05/29/26 EDT · USD

Compare
Low: $6.66Current: $9.07High: $18.90

Key Statistics

Open

$9.40

Day High

$9.87

Day Low

$8.96

Prev. Close

$9.40

VolumeShares traded today.

2.08M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$900.68M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-4.53

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$18.90

52W LowLowest price over the past 52 weeks.

$6.66

50D MAAverage closing price over the last 50 trading days.

$8.21

200D MAAverage closing price over the last 200 trading days.

$9.69

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+10.2%

1M

+15.7%

6M

-2.3%

YTD

-21.1%

1Y

-37.3%

About

Martin Shkreli is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.

ars-pharma.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade SPRY

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.